Market Overview

UPDATE: Stifel Nicolaus Raises PT on Sabra Health Care REIT Post Preferred Offering

Related SBRA
Benzinga's Top Initiations
Wells Fargo Initiates Sabra Healthcare At Market Perform

Stifel Nicolaus maintained Sabra Health Care REIT (NASDAQ: SBRA) with a Buy rating and raised the price target from $29.00 to $30.00.

Stifel Nicolaus analyst Robert Mains wrote, "Yesterday, Sabra priced 5 million shares of 7.125% cumulative redeemable preferred stock at $25. The deal was upsized considerably from 2 million shares. Assuming an additional 750,000 shares for the underwriters' overallotment, Sabra will use net proceeds of $138.2 million to pay down its revolver ($92.5 million outstanding as of December 31) and to fund future acquisitions. […] We had modeled Sabra raising $100 million this year through an at-the-market equity program. In our view, the preferred offering obviates the need for additional equity capital until 2014."

Sabra Health Care REIT closed at $28.40 on Thursday.

Latest Ratings for SBRA

DateFirmActionFromTo
Dec 2014JefferiesDowngradesBuyHold
Nov 2014Stifel NicolausMaintainsBuy
Oct 2014Wells FargoInitiates Coverage onMarket Perform

View More Analyst Ratings for SBRA
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings

 

Related Articles (SBRA)

Around the Web, We're Loving...

Get Benzinga's Newsletters